Shares of China Life Insurance fell sharply in both Hong Kong and Mainland China trade on Thursday after the company disclosed a fourth-quarter setback that undercut an otherwise strong annual performance.
In Hong Kong trading, China Life tumbled nearly 8%, while its Shanghai-listed shares fell by more than 5%.
For the full year, China Life recorded a 44% increase in net profit, reaching 154.08 billion yuan ($22.33 billion). Total revenues for the year rose 16.5% to 615.07 billion yuan.
Despite the strong yearly numbers, the insurer posted a fourth-quarter loss. The company’s total annual profit was smaller than its January-September result of 167.95 billion yuan, an outcome that implies a Q4 loss of 13.87 billion yuan. Revenue growth in the final quarter was marginal, affected by rising investment losses and impairment charges during the period.
Executives and investors flagged that the Q4 slowdown largely offset the broader gains posted across the year. The weak quarter coincided with signs of a broader economic softening in China. Gross domestic product growth slowed to its weakest pace in nearly three years in the fourth quarter, driven by subdued consumer spending and fragile business sentiment.
Market dynamics also contributed to the pressure on China Life’s stock. Wild swings in Chinese equity markets through the fourth quarter increased volatility and amplified the impact of the insurer’s substantial equity holdings, leaving the company vulnerable to broader market weakness.
That said, China Life’s core insurance franchise showed resilience. The company reported a notable increase in new business value, which climbed 35.7% to 45.75 billion yuan, indicating sustained strength in its underlying insurance operations even as investment-related losses weighed on short-term profitability.
What this means
- The annual results signal underlying operational strength, with robust revenue and net profit growth for 2025.
- Short-term investment and impairment losses in Q4 eroded quarterly profitability and prompted sharp share-price moves.
- Broader macroeconomic weakness and market volatility in China exacerbated the equity reaction given the insurer’s large stock exposure.
Further context and limitations
The company-provided figures establish the arithmetic showing the Q4 deficit: an annual profit below the January-September aggregate implies a fourth-quarter loss of 13.87 billion yuan. Revenue expansion for the quarter was only marginal, with investment and impairment factors identified as the primary drags. Beyond these disclosures, details about the composition of investment losses or impairment categories were not provided in the company’s reported figures.